Mutations with a higher MAF in African Americans with colon cancer could provide a particularly valuable therapeutic target, and the unique regulation of the parent gene (MYLK) by its pseudogene (MYLKP1) provides a possible mechanistic explanation for the increased severity of colon cancer and its development at younger ages in African Americans [49]. This evidence concerns the gene MYLK and colonic neoplasm.